Deals

BG Medicine Closes $10M CMPO at 19% Discount via Lazard

By |

BG Medicine, Inc. (BGMD) announced that it has raised $10,000,600 in a CMPO/Overnight transaction. The common stock was sold at $1.55 per share, an approximate 19% discount to the market price ($1.92) of BGMD at deal announcement. Lazard acted as Sole Book Runner on the transaction. Underwriter counsel was Proskauer Rose and issuer counsel was Mintz, Levin, Cohn, Ferris, Glovsky & Popeo. The transaction is expected to close by 04/08/2014.

Deals

Cytomedix Raises $2M at Slight Premium from Anson Capital

By |

Cytomedix, Inc. CMXI announced that it has raised $2,000,000 in a Common Stock transaction. The common stock was sold at $0.52 per share, an approximate 4% premium to the market price $0.50 of CMXI at deal announcement. A series of 2,884,615 60-Month Warrants with an exercise price of $0.52 per share 4% premium was issued to the investors in this transaction. BTIG, LLC acted as the exclusive agent on the transaction and the investor was Anson Capital.This Placement is part of a $11 million financing. The other $9 million was funded in the form of Convertible Notes.